ABL Bio Inc.
A global leader in bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases.
64 employees · est. 2016 · Korea South
CASI Pharmaceuticals, Inc.
Bringing life-changing therapeutics to China and the world.
44 employees · est. 1991 · Rockville, United States
CASI Pharmaceuticals, Inc. is the older company (2016 vs 1991); ABL Bio Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | ABL Bio Inc. | CASI Pharmaceuticals, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2016 | 1991 older |
| Headquarters | ||
| Headquarters | Korea South | Rockville, United States |
| Employees | ||
| Employees | 64 larger | 44 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | IPO | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $49.12B | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 6 | 10 |
| Services | ||
| Services | Development of innovative therapeutic drugs, Research and development of cancer and neurodegenerative disease treatments, Creating and managing biopharmaceutical platforms, Clinical trials and regulatory approval processes | Not tracked yet |
| Target Customers | ||
| Target Customers | Healthcare providers, Patients with cancer and neurodegenerative diseases, Pharmaceutical companies, Medical researchers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Bispecific Antibody Therapeutics, Immuno-Oncology, Neurodegenerative Diseases, Grabody-T, Grabody-I, Grabody-B, 4-1BB Engagement, Blood-Brain Barrier Penetration, Clinical Stage Drug Candidates, Pre-Clinical Stage Drug Candidates, Antibody Drug Conjugate, CNS Targets, Strategic Partnerships, Next-Generation Antibody | Biopharmaceuticals, Therapeutics Development, Oncology Treatments, Hematology, Drug Commercialization, Global Drug Development, Clinical Stage Drug Candidates, Regulatory Expertise, Acquisitions, Licensing, Drug Portfolio, FDA-approved Drugs, Pharmaceutical Products, Innovative Therapies, China Market Expansion |
| Website | ||
| Website | ablbio.com | casipharmaceuticals.com |
About ABL Bio Inc.
ABL Bio Inc., founded in 2016 and headquartered in Korea South, stands as a prominent figure in the biotechnology space. Known for being a global leader in bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases, the company has carved out a niche in delivering innovative...
About CASI Pharmaceuticals, Inc.
CASI Pharmaceuticals, Inc. is a U.S. NASDAQ-listed biopharmaceutical company that focuses on developing and accelerating the launch of innovative therapeutics and pharmaceutical products in China, U.S., and throughout the world. With offices in Rockville, Maryland, and a wholly owned subsidiary in B...
We will tell you when either one moves
BounceWatch watches ABL Bio Inc. and CASI Pharmaceuticals, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at ABL Bio Inc. and CASI Pharmaceuticals,... — by email.
Frequently Asked Questions
Compare ABL Bio Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at ABL Bio Inc. on 15 Jun 2026, and CASI Pharmaceuticals, Inc. on 3 Dec 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
